JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

J Am Coll Cardiol, 2006; 48:593-594, doi:10.1016/j.jacc.2006.05.006 (Published online 11 July 2006).
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
j.jacc.2006.05.006v1
48/3/593    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JACC
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nebeker, J. R.
Right arrow Articles by Feldman, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nebeker, J. R.
Right arrow Articles by Feldman, M. D.

CORRESPONDENCE: LETTER TO THE EDITOR

Reply

Jonathan R. Nebeker, MS, MD*, Renu Virmani, MD, Charles L. Bennett, MD, PhD, MPP and Marc D. Feldman, MD, FACC

* VA Salt Lake City Health Care System, 500 Foothill Boulevard, Salt Lake City, Utah 84148 (Email: jonathan.nebeker{at}hsc.utah.edu).

We appreciate the letter by Dr. Kounis and colleagues that expands upon our discussion of the literature on stent-associated hypersensitivity (1). In conjunction with the RADAR (Research on Adverse Drug events And Reports) project (2), we have started a protocol that incorporates some of the suggestions of Dr. Kounis and colleagues. This protocol includes skin tests to stent components and laboratory tests. It also features a methodical approach to dechallenge and rechallenge (3) for concomitant medication while maintaining antiplatelet coverage. To refer patients, please contact Dr. Marc Feldman, Associate Professor, Department of medicine, University of Texas, San Antonio (E-mail: feldmanm@uthscsa.edu).


   References
Top
 References
 

  1. Nebeker JR, Virmani R, Bennett CL, et al. Hypersensitivity cases associated with drug-eluting coronary stentsa review of available cases from the Research on Adverse Drug events And Reports (RADAR) project. J Am Coll Cardiol 2006;47:175-181.[Abstract/Free Full Text]
  2. Bennett CL, Nebeker JR, Lyons EA, et al. The Research on Adverse Drug events And Reports (RADAR) project JAMA 2005;293:2131-2140.[Abstract/Free Full Text]
  3. Nebeker JR, Barach P, Samore MH. Clarifying adverse drug eventsa clinician’s guide to terminology, documentation, and reporting. Ann Intern Med 2004;140:795-801.[Abstract/Free Full Text]

Related articles in JACC:

Allergic Reactions Following Implantation of Drug-Eluting Stents: A Manifestation of Kounis Syndrome?
Nicholas G. Kounis, George N. Kounis, Sophia N. Kouni, George D. Soufras, Constantinos Niarchos, and Andreas Mazarakis
JACC 2006 48: 592-593. [Full Text]  




This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
j.jacc.2006.05.006v1
48/3/593    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JACC
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nebeker, J. R.
Right arrow Articles by Feldman, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nebeker, J. R.
Right arrow Articles by Feldman, M. D.

HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK